Comunicati.net - Comunicati pubblicati - Comuni Comunicati.net - Comunicati pubblicati - Comuni Fri, 23 Feb 2018 03:37:51 +0100 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://zend.comunicati.net/comunicati/istituzioni/comuni/1 Latin America Respiratory Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Wed, 21 Feb 2018 11:34:12 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/470579.html http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/470579.html pbi pbi

Latin America Respiratory Devices Market: By Device Type (Therapeutic Devices (Positive Airway Pressure (PAP) Devices, Oxygen Concentrators , Humidifiers, Nebulizers, and Others), Diagnostic Devices (Spirometers, Peak Flow Meters, and Others), Monitoring Devices (Pulse Oximeters, Capnographs, and Gas Analyzers), Consumables & Disposables (Nasal Cannulas, Filters, Disposable Masks, and Others)), By Distribution Channel (Hospitals, Ambulatory Care, and Homecare), and By Country (Brazil, Argentina, Mexico, and Rest of Latin America) – Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 

 

 

Latin America Respiratory Devices Market Report Description:

Latin America respiratory devices market report gives a comprehensive outlook on respiratory devices adoption pattern across the region with special emphasis on key countries such as Brazil, Argentina, Mexico, and Rest of Latin America. The report on Latin America respiratory devices market gives historical, current, and future market sizes (US$ Mn) on the basis of device type, distribution channel and country. This report presents Latin America respiratory devices market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the Latin America respiratory devices market. In addition, Latin America respiratory devices market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Latin America respiratory devices market to better equip clients with possible investment opportunities across the regions (Country Investment Hot-Spots) and market unmet needs. Key stakeholders of the Latin America respiratory devices market report include raw material suppliers, manufacturers, marketers, policy makers, and healthcare service providers, who are engaged in usage and advocacy of respiratory devices.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/latin-america-respiratory-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Latin America Respiratory Devices Market:

Latin America Respiratory Devices market was valued around US$ 1,700 Mn in 2016 and poised to grow around 9.0% CAGR over 2017-2023.

 

Competition Assessment

Key players profiles in the Latin America Respiratory Devices market include:

·         Masimo Corporation

·         ResMed, Inc.

·         Fisher and Paykel Healthcare Limited

·         Philips Healthcare

·         Medtronic plc

·         Becton Dickinson and Company

 

Players in the Latin America respiratory devices market are entering into partnerships and collaborations, launching products in the market to garner larger market share

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/latin-america-respiratory-devices-market/#ulp-c654SbFYO64MsOhu

 

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market 

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/latin-america-respiratory-devices-market/#ulp-14mlyhjMGhVjZqa3

 

 

Detailed Segmentation

By Device Type

·         Therapeutic Devices

o    Positive Airway Pressure (PAP) Devices

o    Oxygen Concentrators

o    Humidifiers

o    Nebulizers

o    Others

·         Diagnostic Devices

o    Spirometers

o    Peak Flow Meters

o    Others

·         Monitoring Devices

o    Pulse Oximeters

o    Capnographs

o    Gas Analyzers

·         Consumables & Disposables

o    Nasal Cannulas

o    Filters

o    Disposable Masks

o    Others

By Distribution Channel

·         Hospitals

·         Ambulatory Care

·         Homecare

By Country

·         Brazil

·         Argentina

·         Mexico

·         Rest of Latin America

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/latin-america-respiratory-devices-market/

]]>
Latin America Plant Growth Regulators Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Wed, 21 Feb 2018 11:10:37 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/veneto/comune_di_peschiera_del_garda/470574.html http://zend.comunicati.net/comunicati/istituzioni/comuni/veneto/comune_di_peschiera_del_garda/470574.html pbi pbi

Latin America Plant Growth Regulators Market: By Product Type (Cytokinins, Auxins, Gibberellins, and Others), By Crop Type (Fruits & Vegetables, Grains & Cereals, Oil seeds, Turf & Ornamental Grass, and Others), and By Country (Brazil, Argentina, Mexico, and Rest of Latin America) – Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 

 

Latin America Plant Growth Regulators Market Report Description:

Latin America plant growth regulators market report gives a comprehensive outlook on plant growth regulators adoption pattern across the region with special emphasis on key countries such as Brazil, Argentina, Mexico, and Rest of Latin America. The report on plant growth regulators market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, crop type and country. This report presents plant growth regulators market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the plant growth regulators market. In addition, plant growth regulators market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed plant growth regulators market to better equip clients with possible investment opportunities across the regions (Country Investment Hot-Spots) and market unmet needs. Key stakeholders of the Latin America plant growth regulators market report include raw material suppliers, manufacturers, marketers, policy makers, and farming agencies, who are engaged in usage and advocacy of plant growth regulators.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/latin-america-plant-growth-regulators-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Latin America Plant Growth Regulators Market:

Latin America plant growth regulators market was valued around US$ 580 Mn in 2016 and poised to grow around 3.7% CAGR over 2017-2023.

 

Competition Assessment

Key players profiles in the Latin America plant growth regulators market include:

·         BASF SE

·         Bayer Crop Science

·         DuPont

·         FMC Corporation

·         Tata Chemicals Limited

·         Xinyi Industrial Co Ltd.

Players in the Latin America plant growth regulators market are entering into partnerships and collaborations, launching products in the market to garner larger market share

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/latin-america-plant-growth-regulators-market/#ulp-c654SbFYO64MsOhu

 

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/latin-america-plant-growth-regulators-market/#ulp-14mlyhjMGhVjZqa3

 

 

Detailed Segmentation

By Product Type

·         Cytokinins

·         Auxins

·         Gibberellins

·         Others

By Crop Type

·         Fruits & Vegetables

·         Grains & Cereals

·         Oil seeds

·         Turf & Ornamental Grass

·         Others

By Country

·         Brazil

·         Argentina

·         Mexico

·         Rest of Latin America

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/latin-america-plant-growth-regulators-market/]]>
Europe Portable Ultrasound Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Wed, 21 Feb 2018 10:08:55 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/lombardia/470563.html http://zend.comunicati.net/comunicati/istituzioni/comuni/lombardia/470563.html pbi pbi

Europe Portable Ultrasound Devices Market: By Device Type (Hand Held Devices and Mobile Devices), By Application (Cardiovascular, Obstetrics & Gynaecology, Musculoskeletal, Gastric, and Others) By End User (Hospitals, Clinics, Diagnostics Centers, and Others), and Country (Germany, France, U.K, Italy, Spain, Russia, Poland, and Rest of Europe) – Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 

 

 

Europe Portable Ultrasound Devices Market Report Description:

Europe portable ultrasound devices market report gives a comprehensive outlook on portable ultrasound devices across the region with special emphasis on key countries such as Germany, France, U.K, Italy, Spain, Russia, and Poland. The report on portable ultrasound devices market gives historical, current, and future market sizes (US$ Mn) on the basis of device type, application, end users, and country. Europe portable ultrasound devices market report presents the market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Europe portable ultrasound devices market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Europe portable ultrasound devices market to better equip clients with possible investment opportunities across the countries (Country Investment Hot-Spots) and market unmet needs. Key stakeholders of the Europe portable ultrasound devices market report include component suppliers, manufacturers, marketers, hospitals, physician offices, policy makers, and healthcare service providers, who are engaged in usage and advocacy of portable ultrasound devices.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/europe-portable-ultrasound-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Europe Portable Ultrasound Devices Market:

Europe portable ultrasound devices market was valued around US$ 420 Mn in 2016 and poised to grow around 5.5% CAGR over 2017-2023.

 

Competition Assessment

Key players profiles in the Europe portable ultrasound devices market include:

·         Analogic Corporation (U.S)

·         Esaote SpA (Italy)

·         Fujifilm Holdings Corporation (Japan)

·         General Electric Corporation (U.S.)

·         Hitachi, Ltd. (Japan)

·         Koninklijke Philips N.V. (Netherlands)

·         Siemens Ltd. (Germany)

·         Toshiba Corporation (Japan)

Players in the Europe portable ultrasound devices market are entering into partnerships and collaborations, launching newer products in the market to garner larger market share

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/europe-portable-ultrasound-devices-market/#ulp-c654SbFYO64MsOhu

 

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/europe-portable-ultrasound-devices-market/#ulp-14mlyhjMGhVjZqa3

 

 

Detailed Segmentation

By Device Type

·         Hand Held Devices

·         Mobile Devices

By Application

·         Cardiovascular

·         Obstetrics & Gynaecology

·         Musculoskeletal

·         Gastric

·         Others

By End User

·         Hospitals

·         Clinics

·         Diagnostics Centers

·         Others

Country

·         Germany

·         France

·         UK

·         Italy

·         Spain

·         Russia

·         Poland

·         Rest of Europe

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/europe-portable-ultrasound-devices-market/

]]>
Wheat Protein Market Competition and Forecast - Market Size by Players, Type, Application Forecast Wed, 21 Feb 2018 08:11:03 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/friuli_venezia_giulia/470553.html http://zend.comunicati.net/comunicati/istituzioni/comuni/friuli_venezia_giulia/470553.html suraj taur suraj taur Market Scenario:

Wheat protein is a plant based protein extracted from wheat grains. It comprises of two insoluble protein groups known as gliadin and glutenin. The three common types of wheat protein include wheat gluten, wheat protein isolates, and textured wheat protein. It is widely used in food industry for its elastic texture which provides dough strength.

Increasing demand for efficient and cost effective ingredients in sports drinks & food is boosting the growth of wheat protein market. Moreover, increasing health conscious population and growing trend of adding functional foods and nutritional supplements in diet is propelling the growth of wheat protein market. Globally, wheat protein is witnessing high demand, which is driving greater private investments by companies involved in the wheat protein market, to gain consumer attention and encourage purchasing. Also, companies manufacturing plant based protein products in the North American and European region are spending more on marketing activities to promote wheat protein among the consumers in these regions.

Additionally, the enhancement of the product coupled with technological advancements is considered to be one of the significant reasons for the increasing growth of the wheat protein market during the forecast period, 2017-2023. However, possible side effects associated with wheat protein such as gluten intolerance may hamper the growth of the market.

Get a Sample Report @ https://www.marketresearchfuture.com/reports/wheat-protein-market-5444

Key Players:

Some of the key players profiled in the global wheat protein market: Cargill Inc. (U.S.), Roquette Freres S.A. (France), Archer-Daniels-Midland Company (U.S.), Manildra Group (Australia), MGP Ingredients, Inc. (U.S.), Tereos SA (France), Permolex International, L.P. (Canada), Crespel & Deiters GmbH & Co. KG (Germany), Hermann Kroener GmbH (Germany), and Chamtor SA (France)

Key Findings:

  • Wheat protein have a massive opportunity in the functional food industry
  • Asia Pacific is the fastest growing region in the wheat protein market. India and China has shown huge potentials for wheat protein market share during the reviewed period of 2017-2023
  • Jan 2018, leading European organic and ‘clean-label’ starch producer Kroner-Starke has introduced a new range of clean label wheat proteins to the German and European market.

Segments:

The global wheat protein market is segmented into type, form, and application.

On the basis of the type, it is segmented into wheat gluten, wheat protein isolate, textured wheat protein, and others. Among all the types, the wheat gluten segment is dominating the market followed by the textured wheat protein owing to the presence of high protein content and wide range of product applicability.

On the basis of the form, the wheat protein market is segmented into dry and liquid. The dry form segment is dominating the market owing to better stability and higher shelf-life.

On the basis of the application, the wheat protein market is segmented into bakery and confectionery, snacks, nutritional bars & drinks, processed meat, pet food, and others. The bakery and confectionary segment is dominating the market. However, the pet food segment is anticipated to grow substantially over the estimated period.

Access Report Details @ https://www.marketresearchfuture.com/reports/wheat-protein-market-5444

Regional Analysis:

The global wheat protein market is segmented into North America, Europe, Asia Pacific, and rest of the world (RoW). The North American region is dominating the wheat protein market followed by Europe owing to increasing demand for high protein food and beverage products. Additionally, the major key players are actively involved in the research & developments of the product conforming to North American regulations for food fortification with wheat protein.

 

Asia Pacific is projected to be the fastest growing region over the forecasted period. India and China are the major contributors in this region owing to increasing health awareness and increase in consumption of healthy foods. Latin America is also expected to witness moderate growth over the estimated period in which Brazil and Mexico are the major contributors.

]]>
Livestock Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Tue, 20 Feb 2018 14:00:33 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/470460.html http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/470460.html pbi pbi

Market Outline: Livestock Pharmaceuticals Market 

Livestock pharmaceuticals are used to treat various diseases in animals such as infectious diseases, parasitic diseases, and inflammatory diseases among others. Vaccines are administered to livestock for the prevention of various diseases which increase the immunity of the livestock and makes animal healthy. Livestock pharmaceuticals can be administered as solids or liquids directly to the livestock or some pharmaceuticals can be mixed with the animal feed.

 

Market Dynamics: Livestock Pharmaceuticals Market

Increase in the prevalence of various livestock diseases such as bird flu in poultry, rise in animal welfare expenditure, government initiatives for the animal health management, and rise in demand for healthy meat and other livestock products are anticipated to fuel the livestock pharmaceuticals market. Moreover, rise in disposable income, increase in the awareness about livestock diseases and treatment, and rise in R&D activities for the innovation of newer therapeutics and vaccines might bolster the livestock pharmaceuticals market. However, stringent regulatory guidelines for veterinary medicine approval, ban of certain antibiotics used in the animal diseases, poor availability of drugs in the underdeveloped regions, and dearth of skilled veterinary professionals are hampering the growth of livestock pharmaceuticals market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/livestock-pharmaceuticals-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Market Scope: Livestock Pharmaceuticals Market

Livestock pharmaceuticals market is segmented on the basis of drug class, disease type, route of administration, livestock type, and distribution channel

Based on the drug class, livestock pharmaceuticals is segmented into the following:

·         Vaccines

·         Antivirals

·         Antibiotics

·         Parasiticides

·         Anti-inflammatory drugs

·         Others

Based on the disease type, livestock pharmaceuticals market is segmented into the following:

·         Neurological disorders

·         Infectious diseases

·         Viral diseases

·         Bacterial diseases

·         Fungal diseases

·         Others

Based on the route of administration, livestock pharmaceuticals market is segmented into the following:

·         Oral

·         Parenteral

·         Topical

·         Others

Based on the livestock, livestock pharmaceutical market is segmented into the following:

·         Poultry

·         Aquatic Animals

·         Swine

·         Equine

·         Sheep

·         Cattle

·         Others

Based on the distribution channel, livestock pharmaceuticals market is segmented into the following:

·         Veterinary hospitals

·         Veterinary pharmacies

·         online pharmacies

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/livestock-pharmaceuticals-market/#ulp-c654SbFYO64MsOhu

 

 

Market Summary: Livestock Pharmaceuticals Market

Livestock pharmaceuticals market growing at a significant CAGR owing to increase in the R&D activities for the innovation of newer drugs for various livestock diseases. Increase in the prevalence of various livestock diseases, rise in demand for healthy meat and other livestock products, increase in the farming of aquatic animals might propel the livestock pharmaceuticals market over the forecast period. Acquisitions & mergers, collaborations, and product launching are the strategies followed by the companies for increasing their revenue share in livestock pharmaceuticals market. For instance, in November 2014, Merck Animal Health launched Finadyne a transdermal non-steroidal anti-inflammatory drug used in cattle for the treatment of pyrexia associated with bovine respiratory disease. In addition, in March 2016, Zoetis Inc. inked an agreement with sanofi’s Merial unit for diversifying the product portfolio and marketing the vaccines and drugs for dairy cattle in India.

 

Regional Analysis:  Livestock Pharmaceuticals Market

Geographically, livestock pharmaceuticals market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Increase in the R&D activities for the development of newer drugs by several U.S. pharmaceutical companies, rise in awareness about the veterinary diseases and treatment, increase in the animal welfare expenditure, and rise in product approvals for livestock diseases are anticipated to propel the North America livestock pharmaceuticals marketEurope livestock pharmaceuticals marketgrowth driven by rise in the production of aquatic animals in Norway, Denmark, Ireland, and other European countries, increase in the demand for healthy meat and other livestock products, rise in the disposable income, and increase in the prevalence of zoonotic diseases. However, Asia Pacific livestock pharmaceuticals market growing at significant rate owing to increase in population demanding for quality meat, launching of newer drugs in Asia Pacific region, and industrialization of poultry sector in the region.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/livestock-pharmaceuticals-market/#ulp-14mlyhjMGhVjZqa3

 

 

Market Participants: Livestock Pharmaceuticals Market

Some of the players in livestock pharmaceuticals market are Merck Animal Health (U.S.), Zoetis Inc. (Pfizer) (U.S.), Boehringer Ingelheim (Germany), Ceva Animal Health (France), Bayer Animal Health (Germany), Virbac Inc. (France), Elanco Animal Health (U.S.), Eco Animal Health (U.K.), and Heska Corporation (U.S.) to name a few.

 

Notable Market Developments: Livestock Pharmaceuticals Market

·         In July 2017, ECO Animal Health received FDA approval for Aivlosin an antibiotic used in the treatment of major enteric and respiratory diseases in poultry and swine

·         In March 2017, Merck Animal Health acquired Brazilian company Vallee S.A. for strengthening its livestock pharmaceuticals product portfolio

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/livestock-pharmaceuticals-market/

]]>
Europe Anti-Aging Products Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Tue, 20 Feb 2018 13:28:58 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/470455.html http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/470455.html pbi pbi

Europe Anti-Aging Products Market: By Product Type (Personal Care Products (Botulinum Toxins, Chemical Peels, Derma Fillers, Mosturizers, Sunscreen Products, Hair Products, Eye Care Products, and Others) and Devices (Microderm Abrasion Devices, Laser Devices, Radiofrequency Devices, Breast Implants, and Other Devices)), By Application (Skin Care, Wrinkles, Pigmentation, Adult Acne, Hair Care, Eye-Care, and Body care (Breast Augmentation & Cellulite Reduction)), By Demographics (Baby Boomers, Generation X, and Generation Y) By Distribution Channel (Specialist Cosmetic Stores, Hairdressing and Beauty Saloon, Department Stores, Direct Selling, Pharmacy/Drug Stores, Supermarkets/Hypermarkets, and Online), and Country (Germany, France, U.K, Italy, Spain, Russia, Poland, and Rest of Europe) – Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 

 

 

Europe Anti-Aging Products Market Report Description:

Europe Anti-Aging Products market report gives a comprehensive outlook on Anti-aging products and devices across the region with special emphasis on key countries such as Germany, France, U.K, Italy, Spain, Russia, and Poland. The report on anti-aging products market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, demographics, distribution channel, and country. Europe anti-aging products market report presents the market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Europe anti-aging products market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Europe anti-aging products market to better equip clients with possible investment opportunities across the countries (Country Investment Hot-Spots) and market unmet needs. Key stakeholders of the Europe anti-aging products market report include raw material suppliers, manufacturers, marketers, hospitals, physician offices, policy makers, and healthcare service providers, who are engaged in usage and advocacy of anti-aging products.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/europe-anti-aging-products-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Europe Anti-Aging Products Market:

Europe Anti-Aging Products market was valued around US$ 13,400 Mn in 2016 and poised to grow around 5.5% CAGR over 2017-2023.

 

Competition Assessment

Key players profiled in the Europe Anti-Aging Products market include:

·         Allergan Inc.

·         Alma Lasers Ltd

·         Beiersdorf AG

·         Coty Inc.

·         Cynosure Inc.

·         L’Oreal, SA

·         Lumenis Ltd

·         Personal Microderm

·         Photomedex Inc.

·         Solta Medical Inc.

Players in the Europe Anti-Aging Products market are entering into partnerships and collaborations, launching newer products in the market to garner larger market share

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/europe-anti-aging-products-market/#ulp-c654SbFYO64MsOhu

 

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/europe-anti-aging-products-market/#ulp-14mlyhjMGhVjZqa3

 

 

Detailed Segmentation

By Product Type

·         Personal Care Products

o    Botulinum Toxins

o    Chemical Peels

o    Derma Fillers

o    Mosturizers

o    Sunscreen Products

o    Hair Products

o    Eye Care Products

o    Others

·         Devices

o    Microderm Abrasion Devices

o    Laser Devices

o    Radiofrequency Devices

o    Breast Implants

o    Other Devices

By Application

·         Skin Care

o    Wrinkles

o    Pigmentation

o    Adult Acne

·         Hair Care

·         Eye-Care

·         Body care

·         Breast Augmentation & Cellulite Reduction

By Demographics

·         Baby Boomers

·         Generation X

·         Generation Y

By Distribution Channel

·         Specialist Cosmetic Stores

·         Hairdressing and Beauty Saloon

·         Department Stores

·         Direct Selling

·         Pharmacy/Drug Stores

·         Supermarkets/Hypermarkets

·         Online

Country

·         Germany

·         France

·         K

·         Italy

·         Spain

·         Russia

·         Poland

·         Rest of Europe

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/europe-anti-aging-products-market/

]]>
Middle East and Africa Optical Imaging Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Tue, 20 Feb 2018 10:59:56 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/470428.html http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/470428.html pbi pbi

Middle East and Africa Optical Imaging Market: By Technology (Photoacoustic Imaging, Optical Coherence Tomography (OCT), Hyperspectral Imaging, Near Infrared Spectroscopy and Others), By Application (Dermatology, Ophthalmology, Dentistry, Neurology, Cardiology, Oncology and Others), By end user (Hospitals, Research Laboratories, Medical Imaging Centres and Others) and Countries – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 

 

Optical Imaging refers to the use of light as an imaging technique for medical applications. These optical techniques include optical microscopy, spectroscopy, endoscopy, scanning laser ophthalmoscopy, and optical coherence tomography. Optical imaging is an emerging technology with great potential for improving disease prevention, diagnosis and treatment. Furthermore, optical imaging has its application in the preclinical and clinical development of the pharmaceutical and biopharmaceutical products.

 

Middle East and Africa optical imaging market is mainly driven by the increase in prevalence of diseases such as cancer and diabetic retinopathy. In addition growing awareness on early diagnosis of diseases due to the initiatives by the government and non-profit organizations such as World Health Organization (WHO) coupled with company interest in expanding into the emerging markets of Middle East and Africa. However, lack high-cost maintenance and installation costs are expected to hamper the Middle East and Africa optical imaging market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/middle-east-and-africa-optical-imaging-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Middle East and Africa Optical Imaging market is segmented based on technology, application and end user

 

Based on technology, Middle East and Africa optical imaging market is segmented into

·         Photoacoustic Imaging

·         Optical Coherence Tomography (OCT)

·         Hyperspectral Imaging

·         Near Infrared Spectroscopy

·         Others

 

Based on application, Middle East and Africa optical imaging market is segmented into

·         Dermatology

·         Ophthalmology

·         Dentistry

·         Neurology

·         Cardiology

·         Oncology

·         Others

 

Based on end user, Middle East and Africa optical imaging market is segmented into

·         Hospitals

·         Research Laboratories

·         Medical Imaging Centres

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/middle-east-and-africa-optical-imaging-market/#ulp-c654SbFYO64MsOhu

 

Geographically Middle East and Africa Optical Imaging market is segmented into Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of MEA. Gulf Cooperation council countries optical imaging market expected to have significant growth rate owing to the technological advancements and company interest in expanding its distribution into the countries. For instance, in July 2016, SpectraScience has made a deal with Kuwait’s Advanced Medical German Co. to distribute its product line including WavSTAT Optical Biopsy System for screening of colorectal cancer. South Africa optical imaging market is expected to have notable growth rate owing to prevalence of the diseases such as cancer and developing healthcare infrastructure and availability of high patient pool. According to Center for disease prevention and Controll (CDC), every year more than 100000 people diagnosed with cancer in South Africa alone and breast cancer is the majorly affecting cancer in woman worldwide.

 

Key player’s profiles in optical imaging market include, Carl Zeiss AG (Germany), Bioptigen Inc. (U.S.), SpectraScience Inc. (U.S.), Cytoviva Inc. (Aetos Technologies Inc.) (U.S.) , Optical Imaging Ltd. (Israel), Michelson Diagnostics Ltd. (UK.),PerkinElmer Inc. (U.S.), Nikon Corporation (Japan), Raytheon ELCAN Optical Technologies (The Raytheon Company) (U.S.), St. Jude Medical Inc. (U.S.), Somanetics Corporation (U.S.), Volcano Corporation (Volcano Corporation) (Netherlands), Topcon Medical Systems Inc. (Topcon Corporation) (Japan).

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/middle-east-and-africa-optical-imaging-market/#ulp-14mlyhjMGhVjZqa3

 

 

Optical Imaging Market Report Description

 

The Optical Imaging market report gives a comprehensive outlook of optical image systems usage or adoption across the globe with special emphasis on into Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of MEA. This report on Middle East and Africa Optical Imaging market gives historical, current, and future market sizes (US$ Mn) of technology, application, end users, and geographic regions. This report studies Middle East and Africa Optical Imaging market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Middle East and Africa Optical Imaging market report covers newer product introductions and competition analysis with vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analysed Middle East and Africa Optical Imaging market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the Optical Imaging market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply Optical Imaging systems.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/middle-east-and-africa-optical-imaging-market/]]>
North America Residue Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Mon, 19 Feb 2018 13:38:09 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/lombardia/470315.html http://zend.comunicati.net/comunicati/istituzioni/comuni/lombardia/470315.html pbi pbi

By Residue Type [Toxins (Mycotoxins, Others), Pesticide Residues (Insecticide, Herbicide, Fungicide, Others), Food Allergens, Veterinary Drugs, Heavy Metals, By Technology (Immunoassay, Spectroscopy, Chromatography, Others)], By Application (Dairy products, Fruits & Vegetables, Meat & Poultry, Cereals, Grains & Pulses, Processed Foods, Functional Food Ingredients, Nuts, Seed & Spice, Others) and Country (U.S., Canada) – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 

 

North America Residue Testing Market Report Description: 

 

 

North America Residue Testing Market report gives a comprehensive outlook on North America Residue Testing across the region with special emphasis on countries U.S., Canada. This report on North America Residue Testing Market gives historical, current, and future market sizes (US$ Mn) of residue type, technology, application and countries. This report studies North America Residue Testing Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed North America Residue Testing market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Opportunities).

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/north-america-residue-testing-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

North America Residue Testing Market:

 

North America Residue Testing Market estimated to be valued over US $1,000 Mn in 2016 and expanding at a growth rate about 4% from 2017 to 2023.

 

 

How the stringent government regulations affect North America residue testing market?

 

Surge in the stringent government regulations, rising awareness among the people, frequent pesticide residue monitoring programs are witnessed to enhance the market over the forecast period. Increased disposable income, change in consumer dietary habits, adoption of convenience foods, surge in production of milk and meat are expected to create demand for North America Residue Testing.

In U.S., the favorable government policies are enacted on maximum residue limit (MRL) that promotes the residual testing in agriculture based products and foods. Furthermore, U.S. FDA issues drug residue warning letters to the meat producers if any adulterated drugs or drug residues are present in the meat. For instance, In June 2017, U.S. FDA resumed the glyphosate testing in various foods owing to growing concern of glyphosate in various foods and agriculture products.  Furthermore, FDA laboratories also analyzing foods for 2,4-D and other acid herbicides. Glyphosate and 2, 4 D are commonly used weed-killing products in agriculture and these chemicals are carcinogenic in nature.

 

 

Pesticide Residue Testing Market is expected to account for 30.8% revenue share in North America residue testing market and projected to grow at 3.3% CAGR over 2017 to 2023. High usage of herbicides in U.S. is major driving factor of the market.

 

 

Spectroscopy technology segment expected to account for 33.0% revenue share in North America residue testing market and projected to grow at 7.0% CAGR over 2017 to 2023. Surge in adoption of mass spectrometry enables create lucrative opportunities for residue testing market.

 

 

Meat & Poultry Testing Market is projected to represent lucrative market opportunity over the forecast period in North America residue testing market.

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/north-america-residue-testing-market/#ulp-c654SbFYO64MsOhu

 

 

 

U.S. is expected to dominate the North America Residue Testing market.

 

 

U.S. Residue Testing Market is accounted for US $800 million in 2016, and expanding at significant CAGR over the forecast period due to frequent residue monitoring programs in U.S.  The U.S. Department of Agriculture (USDA), Pesticide data program collects the sample from retails outlets and analyzes for multi-residues.

 

 

Canada Residue Testing Market is projected to expand at a CAGR approximately 5.0%, from 2017 to 2023. High amounts of pesticide usage from the decades, increased awareness of health hazards due to pesticide residues, support from the government to enhance residue testing laboratories, stringent regulations are witnessed to fuel demand for residue testing market.

 

 

Competition Assessment

 

Key players’ profiles in the North America Residue Testing market include: SGS SA, Intertek Group plc., Eurofins Scientific, Bureau veritas S.A., ALS Limited, Neogen Corporation, Idexx Laboratories, AsureQuality, Charm Sciences, Inc., Microbac Laboratories, Inc., Unisensor

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/north-america-residue-testing-market/#ulp-14mlyhjMGhVjZqa3

 

 

Key Findings of the Report:

 

·         North America Residue Testing market is expanding approximately 5.0% CAGR over 2017 to 2023.

 

·         U.S. Residue Testing Market is accounted for major revenue share in 2016, and expected to dominate the market over forecast period.

 

·         Based on Application, meat and poultry is expected to expand at significant CAGR over the forecast period.

 

·         Based Residue Type, pesticide residues testing segment accounted for major revenue share in 2016.

Key Features of the Report:

 

·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

 

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

 

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

 

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

 

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

 

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

           Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/north-america-residue-testing-market/

 

]]>
Global Huntington’s Disease Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Mon, 19 Feb 2018 10:54:25 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/lombardia/470282.html http://zend.comunicati.net/comunicati/istituzioni/comuni/lombardia/470282.html pbi pbi

Huntington’s disease is an inherited disorder caused due to degeneration of the nerve cells in the brain. Huntington’s disease signs and symptoms appear in people with 30 to 40 years of age and sometimes disease causes in below 20 years of age group. Most common symptoms of Huntington’s disease include difficulties in learning, lack of flexibility, muscle problems, abnormalities in speech, and lack of impulse control. Moreover, depression is the most common psychiatric disorder occurs with Huntington’s disease and caused due to damage of brain cells and changes in the brain function. There is no permanent treatment for Huntington’s disease however, medications are available to manage the symptoms of Huntington’s disease.

 

 Increase in the prevalence of Huntington’s disease, a rise in R&D activities for the innovation of newer drugs, availability of symptomatic treatment drugs, and rise in the geriatric population is anticipated to fuel the Huntington’s disease treatment market over the forecast period. Moreover, favourable reimbursement policies, a rise in the awareness regarding mental health among key stakeholders, and various pipeline drugs are driving the Huntington’s disease treatment market growth. However, stringent regulatory guidelines and a dearth of treatment options are expected to hinder the growth of Huntington’s Disease Treatment Market

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-huntingtons-disease-treatment-market/#ulp-4H8Z4LpNMLEuOnnx 

 

 

Huntington’s disease treatment market is segmented on the basis of drug class, route of administration, and distribution channel.

 

Based on the drug class, huntington’s disease treatment market is segmented into the following:

·         Anticonvulsants

·         Antidepressants

·         Antidopaminergics

·         Antipsychotics

·         Others

 

Based on the route of administration, huntington’s disease treatment market is segmented into the following:

·         Oral

·         Parenteral

 

Based on the distribution channel, huntington’s disease treatment market is segmented into the following:

·         Hospitals pharmacies

·         Retail pharmacies

·         Online pharmacies

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-huntingtons-disease-treatment-market/#ulp-c654SbFYO64MsOhu

 

 

Huntington’s disease treatment market is growing at a significant CAGR due to increase in the prevalence of huntington’s disease Moreover, government initiations for the prevention of huntington’s disease also expected to propels the huntington’s disease treatment market over the forecast period. In addition, acquisitions & mergers, collaborations, and new product launch are the strategies followed by the companies for increasing their revenue share in huntington’s disease treatment market. For instance, in February 2015, QR Pharma, Inc. collaborated with Rockefeller University for developing a treatment for the huntington’s disease.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-huntingtons-disease-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

 

 

Some of the players in Huntington’s Disease Treatment market are Teva Pharmaceuticals Industries Ltd. (Israel), Valent Pharmaceuticals International Inc. (Canada), Alnylam Pharmaceuticals, Inc. (U.S.), Intellect Neurosciences, Inc. (U.S.), H. Lundbeck A/S (Denmark), F. Hoffmann La Roche Ltd. (Switzerland), QR Pharma, Inc. (U.S.), and Voyager Therapeutics, Inc. (U.S.) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-huntingtons-disease-treatment-market/

]]>
Global Active Pharmaceutical Ingredient (API) Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Mon, 19 Feb 2018 10:31:45 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/sardegna/470277.html http://zend.comunicati.net/comunicati/istituzioni/comuni/sardegna/470277.html pbi pbi

Active pharmaceutical ingredient (API) Market is a part of drug that produces pharmacological effect. Some drugs such as combination therapy have multiple active pharmaceutical ingredients (API) to treat different symptoms in different ways. API’s provide health benefits and play vital role in prevention, treatment and diagnosis. Active Pharmaceutical ingredients may synthesize by chemical process, biotechnological process, and various other processes. Active pharmaceutical ingredients used for making wide range of drugs that used to treat chronic diseases such as cancer, metabolic disorders, cardiovascular disorders, and neurological disorders, and others. Some market players manufacture their own API and others buy from other API manufacturing companies to make drug formulations.

 

Active pharmaceutical ingredient (API) market is driven by various factors such as increase in incidence of chronic diseases, and penetration of healthcare systems in underdeveloped countries increased the consumption of drugs are expected to fuel the growth of API market. Furthermore, surge in healthcare spending, development of healthcare infrastructure around the world enables boost the growth of active pharmaceutical ingredients market. However, unfavourable drug pricing policies in some countries and stringent regulatory requirements are hampering the active pharmaceutical ingredients market.

 

      A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-active-pharmaceutical-ingredient-api-market/#ulp-4H8Z4LpNMLEuOnnx  

 

API market has been segmented based on the type of synthesis, and application area

 

Based on type of synthesis, active pharmaceutical ingredients market is segmented into

·         Biotechnological

·         Synthetic

·         Semi-Synthetic

 

Based on application area, active pharmaceutical ingredients (API) market is segmented into

·         Cardiovascular system

·         Oncology

·         CNS & Neurological system

·         Orthopaedic

·         Endocrinology

·         Pulmonology

·         Gastrointestinal system

·         Nephrology system

·         Ophthalmology

·         Others

 

  To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-active-pharmaceutical-ingredient-api-market/#ulp-c654SbFYO64MsOhu 

 

Active pharmaceutical ingredients (API) market is witnessing robust growth rate over the forecast period. Globally API market is highly fragmented with many players. Market players are banking on mergers and acquisitions to expand their manufacturing capabilities, geographical expansions and to increase the market share. In September 2015, Sun Pharmaceuticals acquired GlaxoSmithKline’s (GSK’s) opiates business in Australia, to strengthen its active pharmaceutical ingredients (API) and analgesic drug segments. In July 2014, Hospira acquired API manufacturing facility and an associated R&D facility from Orchid Chemicals & Pharmaceuticals, an Indian pharmaceuticals company. This acquisition enables Hospira to vertically integrate into the beta-lactam antibiotic APIs. Furthermore, contract API manufacturing is growing at a significant rate owing to the low cost of manufacturing. New treatments for various diseases are expected to spur the demand for active pharmaceutical ingredients (API) across the globe.

 

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-active-pharmaceutical-ingredient-api-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically API market segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts major pie in API market over the forecast period. In addition, rise in biotechnological advances led to rising demand for the active pharmaceutical ingredients in North America region. Asia-Pacific is expected to record the fastest CAGR owing to many manufacturers and favourable government policies in the region. Europe API market is expected to grow at a significant rate during forecast period owing to manufacturers prioritizing high-quality standards, advanced manufacturing installations, and high purity of intermediates. In Europe, Russia is expected to grow with significant CAGR in the API manufacturing market owing to recent entry of many multinational companies and change in government policies are encouraging manufacturers to enter into market.

 

Some of the players in API market are Pfizer, Inc. (U.S.), Sanofi (France), Lonza Group (Switzerland), Boehringer Ingelheim (Germany), Novartis AG (Switzerland), GlaxoSmithKline plc (U.K.), Bristol-Myers Squibb (U.S.), Zhejiang Hisun Pharmaceutical Co., Ltd. (China), Aenova Group GmbH (Germany), Catalent, Inc. (U.S.), Teva Pharmaceutical Industries Ltd., (Israel) Aurobindo Pharma Limited (India), Eli Lilly and Company (U.S.), AbbVie Inc. (U.S.).,  and Merck & Co., Inc. (U.S.) to name a few.

 

 

 

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-active-pharmaceutical-ingredient-api-market/

 

]]>
Protein Bars Market Forecast to 2023 Available in New Report Mon, 19 Feb 2018 08:55:31 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/friuli_venezia_giulia/470258.html http://zend.comunicati.net/comunicati/istituzioni/comuni/friuli_venezia_giulia/470258.html suraj taur suraj taur Market Scenario:

Protein bars are nutritional bars with high protein content. It is available in a wide variety in the market and is a healthy option as a meal substitute. Most protein bars are fortified with a range of vitamins and minerals which is driving the growth of the market. Protein bars are an effective way to reduce cravings and prevent constant snacking. They are available in different flavors such as chocolates, fruits, peanut butter, savory, spices, and others.             

Protein bars are a healthy substitute for a proper meal for individuals who require quick energy. The high protein content in the product is driving the growth of the market. Increasing working population followed by a hectic lifestyle of consumers have provided the best opportunity for protein bars market.

Rising health-conscious population along with increasing disposable income is adding fuel to the market growth of protein bars. Moreover, protein bars are gaining popularity owing to growing trend of health and fitness. However, there is a large number of substitutes for the product available in the market which may hamper the market growth of protein bars. 

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/5417

Key Players:

Some of the key players profiled in the global protein bar market are Atkins Nutritionals, Inc. (U.S.), Clif Bar & Company. (U.S.), General Mills Inc. (U.S.), Kellogg Co. (U.S.), Premier Nutrition (U.S.), Lenny & Larry's Incorporated (U.S.), Mars Incorporated (U.S.), Quest Nutrition (U.S.), Caveman Foods LLC (U.S.), Abbott Nutrition Manufacturing Inc. (U.S.)

 Key Findings:

  • Gluten-free protein bars are gaining acceptance from majority of the population
  • Germany, Canada, Belgium, France, and Italy are the major exporters of protein bars

Segments:

Protein bars market is segmented on the basis of type such as plant protein and animal protein. Among them, the plant protein segment is anticipated to gain substantial growth over the coming years due to increasing demand for gluten-free plant sources among the population suffering from celiac diseases.

On the basis of flavors, protein bars are segmented such as chocolates, fruits, peanut butter, savory, spices, and others. The chocolate segment is witnessed to be dominating among others. However, the fruits and peanut butter segments are expected to have a steady growth over the forecast period.

Based on the distribution channel, protein bars are segmented as store based and non-store based. Protein bars are, however, mainly sold through store based distribution channel among which grocery wholesalers and retail stores are the major contributors.

Access Report Details @ https://www.marketresearchfuture.com/reports/protein-bars-market-5417

 

Regional Analysis:

The global protein bar market is segmented into North America, Europe, Asia Pacific, and rest of the world (RoW). North America is anticipated to be dominating the protein bars market followed by Europe owing to the presence of key players in the U.S. followed by rising inclination towards portable convenience foods. Moreover, in Europe, there is a high inclination towards functional foods and nutritional products which is driving the growth of the market in this region.

 

Asia Pacific is projected to be the fastest growing region for protein bars in which China and Japan are the major contributors followed by India. Moreover, Australia is also witnessed to have a steady growth over the coming years. Owing to increasing trend of health and fitness, protein bars are estimated to grow rapidly over the rest of the world.

]]>
Global Interventional Cardiology Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Mon, 19 Feb 2018 06:58:21 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/470240.html http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/470240.html pbi pbi

Global Interventional Cardiology Devices Market: Interventional cardiology deals with the treatment of various heart diseases by using intravascular catheter-based techniques. Interventional cardiology devices are commonly used in the treatment of coronary artery disease, conventional artery disease, and aneurysm. In this technique, catheter is inserted into any large peripheral artery or vein with the help of fluoroscopy by catheter whole procedure. Interventional cardiology provides controlled bleeding and fast recovery within a short period of time and reduce the complications for patients. The most commonly used interventional cardiology devices include balloon-inflation devices, coronary stents, and cutting balloon catheters among others.

 Global Interventional Cardiology Devices Market Outlook

 Increase in the incidence rate of various cardiovascular diseases, a rise in preference for minimally invasive procedures, growing clinical trials for the novel interventional cardiology devices, and technological advancements of devices are anticipated to fuel the interventional cardiology devices market over the forecast period. Moreover, favourable reimbursement policies for the devices, lifestyle changes, and rise in product launchings might bolster the interventional cardiology devices market. However, stringent regulatory policies, product recall, high cost for the manufacturing of interventional cardiology devices & treatments, and lack of skilled professionals are expected to dampen the Interventional Cardiology Devices Market over the forecast period.

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-interventional-cardiology-devices-market/#ulp-4H8Z4LpNMLEuOnnx 

 

 

 

Interventional cardiology devices market is segmented on the basis of product type, indication, and end user

 

Based on the product type, interventional cardiology devices market is segmented into the following:

·         Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons

·         Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires

·         Stents

·         Catheters

·         Inferior Vena Cava (IVC) Filters

·         Intravascular Ultrasound Systems

·         Left Atrial Appendage (LAA) Devices

·         Others

 

Based on the disease type, interventional cardiology devices market is segmented into the following:

·         Congestive Heart Disease

·         Percutaneous Valve Replacement

·         Percutaneous Valve Repair

·         Coronary Thrombectomy

·         Others

 

Based on the end user, interventional cardiology devices market is segmented into the following:

·         Hospitals

·         Clinics

·         Cardiac Catheterization Labs

·         Ambulatory Surgical Centres

 

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-interventional-cardiology-devices-market/#ulp-c654SbFYO64MsOhu

 

 

Interventional cardiology devices market is growing at a significant CAGR owing to rise in demand for minimally invasive procedures and increase in the prevalence of various cardiac diseases around the globe. According to World Health Organization, approximately 17.3 Mn people died from CVDs in 2008 which is anticipated to reach 23.6 Mn by 2030. Most of the international players are focusing on innovation of novel products with minimally invasive procedures which is expected to upsurge the revenue of interventional cardiology devices market. Moreover, acquisitions & mergers, collaborations, product approvals and launching, and patent fillings are the strategies followed by the companies for dominating the interventional cardiology devices market. For instance, in February 2017, Merit Medical Systems acquired interventional cardiology devices from the Argon Medical Devices and Catheter Connections, Inc. for strengthening its interventional cardiology devices portfolio. In addition, in January 2016, in Europe, Svelte Medical Systems launched Slender a sirolimus eluting coronary stent system used as interventional cardiology device.

 

 

Geographically, interventional cardiology devices market is segmented into North America, Asia Pacific, Middle East and Africa, Latin America, and Europe. North America Interventional cardiology devices market exhibiting lucrative growth due to increase in incidence of various cardiovascular diseases (according to Centres for Disease Control and Prevention 2016, approximately 40,000 children born with congestive heart diseases in U.S.), rise in healthcare expenditure, and rise in R&D activities for the innovation of novel devices. In Europe, higher prevalence of cardiovascular diseases majorly in Bulgaria, Germany, Hungary, Sweden, UK, and France is drive the interventional cardiology market in the region. Furthermore, high adoption of technological advanced devices, rising CE mark approval for various interventional cardiology devices, and rise in demand for minimally invasive procedures are bolster the interventional cardiology devices market in Europe region. However, Asia Pacific expected show significant growth due to growing incidence cardiovascular diseases majorly in India and China and rise in per capita income.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-interventional-cardiology-devices-market/#ulp-14mlyhjMGhVjZqa3

 

 

 

Some of the players in interventional cardiology devices market are Abbott Laboratories (U.S.), Medtronic, Plc. (Republic of Ireland), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), C.R. Bard, Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), Terumo Corporation (Japan), Argon Medical Devices, Inc. (ACI Medical Devices, Inc.) (U.S.), (Svelte Medical Systems, Inc. (U.S.), Cardinal Health, Inc. (U.S.), and Venus Medtech, Inc. (China) to name a few.

 

https://www.precisionbusinessinsights.com/market-reports/global-interventional-cardiology-devices-market/

]]>
Offerta di prestito tra individuo Fri, 16 Feb 2018 17:52:50 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/470029.html http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/470029.html Dombrowski Dombrowski Avete bisogno di assistenza finanziaria per scopi personali o commerciali? Offriamo finanziamenti con un tasso di interesse molto basso del 3% in tutto il mondo. Abbiamo prestiti di 2000 euro a 30.000.000 euro per i clienti interessati. Il nostro programma di prestito è molto semplice e flessibile. Chiunque sia interessato vi preghiamo di contattarci via e-mail per avere maggiori informazioni : franck-renaud.d@outlook.com

]]>
Offerta di prestito tra individuo Fri, 16 Feb 2018 17:52:02 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/470028.html http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/470028.html Dombrowski Dombrowski Avete bisogno di assistenza finanziaria per scopi personali o commerciali? Offriamo finanziamenti con un tasso di interesse molto basso del 3% in tutto il mondo. Abbiamo prestiti di 2000 euro a 30.000.000 euro per i clienti interessati. Il nostro programma di prestito è molto semplice e flessibile. Chiunque sia interessato vi preghiamo di contattarci via e-mail per avere maggiori informazioni : franck-renaud.d@outlook.com

]]>
Food Coating Ingredients Market report predicts impressive growth by 2023 just published Fri, 16 Feb 2018 14:35:56 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/toscana/470008.html http://zend.comunicati.net/comunicati/istituzioni/comuni/toscana/470008.html suraj taur suraj taur Market Overview:

Food coating ingredients are substances added to food to improve its visual appeal. They are used as food toppings in various bakery and confectionary products in order to improve the texture and appearance of cakes, biscuits, cookies, chocolates, toffees and other products. The most commonly used coating ingredients are cocoa & chocolates, sugars & syrups, spices & seasonings, starches, hydrocolloids, fats & oils, crumbs, and flours.

Food coating ingredients market is highly influenced by the growth of processed food industry. They are used in food and beverage industry owing to its attribute of adding taste, texture, appearance, and flavor to the food products. High inclination of growing population towards the appearance of the product is driving the market for food coating ingredients.

Shifting consumption pattern is further adding fuel to the growth of food coating ingredients market. Moreover, rapid growth in technology and continuous efforts in R&D is bringing innovations in coatings, which is further boosting the growth of this market. However, a large number of fats and calories present in coatings is a restraint to the growth of the market. Nevertheless, increasing innovations in sugar-free coatings is an opportunity for the market growth. Additionally, the enhancement of the product coupled with technological advancements is considered to be one of the significant reasons for the increasing growth of the food coating ingredients market during the forecast period, 2017-2023.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/5395

Major Key Players:

Some of the key players profiled in the global food coating ingredients market: E. I. du Pont de Nemours and Company (U.S.), Cargill Inc. (U.S.), Ashland Global Holdings Inc. (U.S.), Archer-Daniels-Midland Company (U.S.), Agrana Beteiligungs Ag (Austria), Dohler Group SE (Germany), PGP International Inc. (U.S.), Tate & Lyle Plc. (U.K), Ingredion Incorporated (U.S.), and Kerry Group Plc. (Ireland)

Key Findings:

Asia-Pacific is the fastest growing region in the food coating ingredients market. India and China are showing huge potentials for food coating ingredients market during the forecast period

Currently, the key players are making huge investments in innovation and expansion of their food coating ingredients business

Europe is dominating the food coating ingredients market followed by North America

Segments:

The global food coating ingredients market is segmented into type and application.

On the basis of the type, it is segmented into cocoa & chocolates, sugars & syrups, spices & seasonings, starches, hydrocolloids, fats & oils, crumbs, flours, and others. Among all, the cocoa & chocolate segment is dominating the market owing to the health benefits associated with its consumption. However, the sugars & syrups segment is projected to witness substantial growth in the coming years owing to its wide range of use in various food products.

On the basis of the application, it is segmented into bakery, confectionery, dairy, frozen foods, RTE meals, snack and nutrition bar, and others. Among all, the bakery segment is dominating the market owing to the high use of food coating ingredients. Moreover, shifting inclination of the population in developed countries towards baked and confectionery products is driving the growth of the market. However, dairy and frozen desserts are likely to witness substantial growth over the estimated period.

Access Report Details @ https://www.marketresearchfuture.com/reports/food-coating-ingredients-market-5395

Regional Analysis:

The global food coating ingredients market is segmented into North America, Europe, Asia Pacific, and rest of the world (ROW). Among these, European region has the major market share. The market is projected to grow at a steady pace in the review period. Asia-pacific will be the fastest growing region in the food coating ingredients market. High growth in emerging economies such as China, India, Japan, Australia, and the Latin American countries, offers ample opportunities for expansion to major players.

 

Moreover, the high consumption of processed and convenience food products in growing economies of Asia-Pacific and Latin America and growing demand for bakery and confectionery products especially in China and India will be the crucial factor underlining the market growth.

]]>
Herbal Tea Market Analysis 2017-2023: Key Findings, Regional Analysis, Key Players Profiles and Future Prospects Fri, 16 Feb 2018 14:18:08 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/toscana/470006.html http://zend.comunicati.net/comunicati/istituzioni/comuni/toscana/470006.html suraj taur suraj taur Market Overview:

Herbal tea is exclusively prepared from plant sources such as spices and herbs. Herbal tea has a higher percentage of antioxidants compared to other form of tea which makes it a preferred choice for the health-conscious consumers. The most common ingredients used in herbal tea are cinnamon, dandelion, chamomile, ginger, turmeric, and lemongrass.

Herbal tea has been found to be superior to black tea in terms of health benefits. Herbal tea is made from spices & herbs having medicinal attributes. The demand for herbal tea is increasing significantly for its various health benefits.

One of the significant reasons for increasing growth of herbal tea is the medicinal benefits. Also, the increased cardiovascular diseases and obesity cases are anticipated to fuel the sales of the herbal tea during the forecast period. The antioxidant property of herbal tea aids blocking the oxidation of low-density lipoprotein and the cholesterol. Apart from that, herbal tea minimizes in the fat reduction which in turn accelerates the demand for herbal tea during the review period.

Also, increasing health conscious people in developed economies is anticipated to boost the sales of herbal tea during the forecast period. Also, the enhancement of livelihood among the consumers in developing economies is also a significant factor for the growth of the herbal tea market over the forecast period.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/5420

Major Key Players:

Some of the key players profiled in the global herbal tea market:  Associated British Foods Plc. (U.K), Dilmah Ceylon Tea Company Plc. (Sri Lanka), ITO EN (North America) Inc. (U.S.), Tata Global Beverages Ltd. (India), The Unilever Group (U.K), Barry's Tea Ltd. (Ireland), R.C. Bigelow, Inc. (U.S.), Celestial Seasonings, Inc. (U.S.), Harney & Sons Tea Corp. (U.S.), and Mighty Leaf Tea Company (U.S.)

Key Findings:

Herbal tea has a massive opportunity in the global beverages market

Asia Pacific is the fastest growing region in the herbal tea market. India and China has shown huge potentials for herbal tea market share during the review period, 2017-2023

Teasane has launched a new health and wellness brand consisting of a full line of products including Teas, Herbal Extracts, Facial Tea Beauty Cream, Supplements and 28-Day Wellness Kits

Segments:

The global herbal tea market is segmented into ingredient, function, packaging, and distribution channel.

On the basis of the ingredient, it is segmented into cinnamon, dandelion, chamomile, ginger, turmeric, lemongrass, and others. Among all the ingredients, the cinnamon segment holds the major market share followed by the dandelion segment. The primary reason for the growth of these ingredients is their extensive use for herbal tea formulation.

On the basis of the function, it is segmented into cognitive health, gut & digestive health, general wellness, and others. Among all the functions, the cognitive health segment is dominating the market. Increasing consumption of herbal tea for stress management is majorly driving the growth of this segment. However, use of herbal tea for the gut & digestive health is also showing popularity among the consumers.

On the basis of the packaging, it is segmented into tea bags, loose leaf, powder, and others. Among all the packaging types, the tea bags segment is dominating the market followed by the loose leaf owing to the ease of use and handling.

On the basis of the distribution channel, it is segmented in store based, and non-store based.  Among both, the store-based distribution channel is dominating the market based on the one-stop shopping experience.

Access Report Details @ https://www.marketresearchfuture.com/reports/herbal-tea-market-5420

Regional Analysis:

The Global Herbal Tea Market is segmented into North America, Europe, Asia Pacific, and rest of the world (RoW). Among all, Asia Pacific region is expected to retain its dominance throughout the forecast period. This is attributed to the increasing per capita disposable income coupled with the rising awareness of health benefits among the consumers in developing economies like India, China, and Indonesia. Additionally, in the Asia Pacific region, China and India offer a lucrative opportunity for the herbal tea manufacturers. Moreover, Europe is projected to witness a steady growth during the review period.

 

North America is estimated to show a slow growth owing to the mature market in the U.S. However, Latin American region is projected to show a high potential in the herbal tea market owing to the rising disposable income in this region.

]]>
Global Animal Feed Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Fri, 16 Feb 2018 13:13:36 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/friuli_venezia_giulia/469997.html http://zend.comunicati.net/comunicati/istituzioni/comuni/friuli_venezia_giulia/469997.html pbi pbi

Animal feed is nutritional food given to domestic animals to increase the overall productivity and provide them with a balanced diet. There are different types of animal feed such as mixed animal feeds, alternative protein food, hay, plants, husks and others, depending on the livestock. Animal feed plays an important part in the food chain and has implications for the composition and quality of the livestock products (milk, meat and eggs) that people consume. Animal feed can be divided into four groups – forages (e.g. grasses), cereals and other home-grown crops; compound feedingstuffs and products and by-products of the human food and brewing industries. The diets of pigs and poultry are different from ruminants. Compound (mixed or manufactured) feeds are supplemented in livestock diets. Vitamins and minerals are provided by separately or by incorporating in the compound feed.

 

 

Rise in consumption of meat, poultry and dairy products, growing concern over an outbreak of animal diseases, growing domestic and international quick-service restaurants in developing countries and demand for high-quality meat products are expected to bolster the animal feed market. Furthermore, rising inclination towards high-protein diets has positively influenced livestock production is the few factors that are driving animal feed market. However, lack of awareness and cost of products may hinder the Animal Feed Marketgrowth.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-animal-feed-market/#ulp-4H8Z4LpNMLEuOnnx 

 

The global animal feed market is segmented on the basis of type of livestock, types of feed and geographical regions.

 

 

Based on the type of animal, the global animal feed market is segmented:

·         Poultry

·         Swine

·         Canine

·         Equine

·         Ovine

·         Bovine

·         Aquaculture

 

Based on the type of feed, the global animal feed market is segmented:

·         Medicated feed

·         Antibiotics

·         Probiotics

·         Proteins

·         Others

·         Non-medicated feed

·         Cereals

·         Fats

·         Oils

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-animal-feed-market/#ulp-c654SbFYO64MsOhu

 

 

 

The feed industry is a major economical component of many countries. According to the AFIA (American Feed Industry Association), an average of $20 billion is annually spent on feed ingredients. The feed industry is the largest purchaser of corn and soybean meal. To enhance the overall production efficiency the feed is added to poultry, swine, cattle and others. Animal feed market is anticipated to have high growth owing to surge in awareness, growth strategies adopted by the key players such as acquisitions, mergers investments and expansions, which enables enhance the product portfolio and reaching out to new markets. For instance, in 2017 Nutreco acquired Hi-Pro feeds, which is a North American animal feed manufacturer.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-animal-feed-market/#ulp-14mlyhjMGhVjZqa3

 

 

The animal feed market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. China is the major meat exporter and producer having strong economic outlook and rapid urbanization. High consumption of protein rich diet like meat, milk, and eggs expected to accelerate the market share over the foresee period. U.S. animal feed market is anticipated expand at significant growth rate due to rising consumption of organic meat over processed products. Emerging economies market is expected to a huge traction due to rise in per capita expenditure coupled with high population in India, China.

 

 

Evonik Industries AG (Germany), Novozymes (Denmark), DSM (Netherlands), Dupont (Danisco) (U.S), Nutreco, BASF SE (Germany), Archer Daniels Midlands (U.S), Charoen Pokphand (Thailand), Alltech Incorporated (U.S), Invivo NSA (France), Cargill Incorporated (U.S) are some of the players in the animal feed market .

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-animal-feed-market/

]]>
Obesity Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Fri, 16 Feb 2018 12:57:57 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/469996.html http://zend.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/469996.html pbi pbi

Obesity is the medical condition occurs due to the excessive or abnormal accumulation of fat inside the body. Obesity is measured with respect to Basal Metabolic Index (BMI). According to world health organization, more than 30 BMI is considered as the obese. Obesity may lead to osteoarthritis, cardiovascular diseases, diabetes, and various types of cancer. The risk factors for obesity include lack of physical exercise, excessive food intake, endocrine disorders, genetic inheritance, and due to some medications.  obesity treatment reduces the body mass either by an increase in calorie consumption or by the decrease in craving.

 Increase in the prevalence of obese population around the globe, increase in R&D activities for the innovation of new treatment, change in lifestyle such as food habits, and genetic inheritance is the major factors anticipated fuel the obesity treatment market over the forecast period. Moreover, increase in awareness about obesity treatment, huge pipeline products available for the obesity treatment, and government initiations for increasing awareness about chronic nature of obesity are propelling the obesity treatment market. However, high cost for R&D activities, alternative treatment for the obesity, adverse effects associated with the treatment, and stringent regulatory guidelines might hinder the growth of Obesity Treatment Market

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-obesity-treatment-market/#ulp-4H8Z4LpNMLEuOnnx 

 

 

 

Global obesity treatment market segmented on the basis of drug type, mechanism of action, distribution mode, route of administration, and distribution channel

 

Based on the medicine type, obesity treatment market segmented into the following:

·         Centrally acting obesity medicines

·         Peripherally acting obesity medicines

 

Based on the mechanism of action, obesity treatment market segmented into the following:

·         Serotonin-Norepinephrine-Dopamine reuptake inhibitors (SNDRIs)

·         Serotonin reuptake inhibitors

·         Sympathomimetic-GABA receptor agonists

·         Sympathomimetics

·         Others

 

Based on the distribution mode, obesity treatment market segmented into the following:

·         Over-the-counter medicines

·         Prescription medicines

 

Based on the route of administration, obesity treatment market segmented into the following:

·         Oral

·         Injectables

 

Based on the distribution channel, obesity treatment market segmented into the following:

·         Hospital pharmacies

·         Retail pharmacies

·         Online pharmacies

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-obesity-treatment-market/#ulp-c654SbFYO64MsOhu

 

 

 

 

Global obesity treatment market expected to grow at a significant CAGR owing to increase in the R&D activities for the innovation of new products and presence of various pipeline products for the treatment of obesity. Increase in the prevalence of obese population fuelling the obesity treatment market growth. According to World Health Organization 2014, more than 39% of adults (600 Mn adults) adults and 42 Mn children were obese. In addition, entry of generic products due to patent expiry of blockbuster treatment also driving the revenue of obesity treatment. For instance, in March 2017, Novo Nordisk has received European Commission marketing authorization approval of Saxenda an injectable obesity drug and launched the same in India market in 2017.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-obesity-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

 

 

Geographically, obesity treatment market segmented into North America, Europe, Middle East and Africa, Latin America, and Asia Pacific. North America has a significant share in global obesity treatment market owing to increase in the R&D activities for the innovation of newer products, rise in prevalence of obese population majorly in U.S. (according to Centers for Disease Control and Prevention 2014, about 36.5% adults were obese in U.S.). In Europe, the obesity prevalence is growing (according to World Health Organization, in Europe more than 30% people were obese) due to changes in lifestyle, food habits, and hectic work schedules. Moreover, launching of new products into the Europe market, the rise in healthcare expenditure, increase in R&D activities, and awareness about the causes of obesity are anticipated to boost the obesity treatment market. However, Asia Pacific is an emerging market owing to increase in the medical tourism majorly in India and China, a rise in adult population, increase in per capita income, and diversification of business into Asia Pacific region by market players.

 

 

Some of the players in  obesity treatmet market are Boehringer Ingelheim GmbH (Germany), Takeda Pharmaceuticals co. Ltd. (Japan), Novo Nordisk A/S (Denmark), GlaxoSmithKline Plc (U.K.), AstraZeneca Plc (U.K.), F. Hoffmann La Roche Ltd. (Switzerland), Pfizer, Inc. (U.S.), Gubra (Denmark), Orexigen Therapeutics Inc. (U.S.), and Eisai Co. Ltd. (Japan) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-obesity-treatment-market/

]]>
Global Interventional Neurology Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Fri, 16 Feb 2018 12:11:11 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/valle_d_aosta/469989.html http://zend.comunicati.net/comunicati/istituzioni/comuni/valle_d_aosta/469989.html pbi pbi

Interventional neurology is a speciality which utilizes the minimally invasive procedures with image-guided techniques for the diagnosis and treatment of various chronic neurological diseases related to veins & arteries of neck, brain, and spine. The most commonly treated diseases with interventional neurology include head and neck tumours, ischemic strokes, meningiomas, spinal vascular malformations, cerebral aneurysm, and intracranial atherosclerosis among others. Different types of materials such as cobalt, platinum, and nitinol are used in neurovascular devices for ischemic stroke prevention and aneurysm.

 

 

Increase in the global aging population, technological advancements in the interventional neurology devices, a rise in prevalence of ischemic stroke and hemorrhagic conditions, and growing demand for minimally invasive procedures are anticipated to fuel the interventional neurology devices market. Furthermore, advantages of an interventional procedure such as the minimal possibility of infection and surgical trauma, favourable reimbursement policies, and rise in product development and commercialization are expected to bolster the interventional neurology devices market over the forecast period. However, stringent regulatory guidelines for the product approvals, a high cost of the treatment, and lack of skilled professionals might impede the growth of  interventional neurology devices market

 

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-interventional-neurology-devices-market/#ulp-4H8Z4LpNMLEuOnnx 

 

 

Interventional neurology devices market has been segmented into product type, technology type, indication, and end user

 

Based on the product type, interventional neurology devices market segmented into the following:

·         Cerebral Balloon Angioplasty and Stenting Systems

o    Embolic Protection Systems

o    Carotid Artery Stents

·         Neurothrombectomy Devices

o    Suction and Aspiration Devices

o    Clot Retrievers

o    Snares

·         Support Devices

o    Catheters

o    Guide Wires

·         Aneurysm Coiling and Embolization Devices

o    Flow Diversion Devices

o    Embolic Coils

o    Liquid Embolic Agents

 

Based on the technology type, interventional neurology devices market segmented into the following:

·         Carotid artery angioplasty and stenting

·         Vertebroplasty

·         Stroke therapy

·         Pre-operative tumour embolization

 

Based on the indication, interventional neurology devices market is segmented into the following:

·         Cerebral aneurysm

·         Ischemic strokes

·         Arteriovenous malformations and Fistulas

·         Others

 

Based on the end user, interventional neurology devices market segmented into the following:

·         Hospitals

·         Neurology Clinics

·         Ambulatory surgical centres

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-interventional-neurology-devices-market/#ulp-c654SbFYO64MsOhu

 

 

Interventional neurology devices market is growing at a significant CAGR owing to increase in the demand for minimally invasive neurological surgical procedures. Rise in the prevalence of neurological disorders (according to World Health Organization, more than 6.8 Mn people are dying from neurological disorders) expected to drive the revenue growth of interventional neurology devices market. Moreover, majority of the market players are focusing on the development of novel devices with minimally invasive techniques. Acquisitions and mergers, collaborations, product approvals, and launchings are strategies followed by the companies for dominating the interventional neurology devices market. For instance, in June 2016, Terumo Corporation acquired Sequent Medical, Inc. for the development of novel medical device for the aneurysm embolization. Moreover, in January 2012, Covidien received FDA approval for the Solitaire revascularization device interventional management of stroke trial.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-interventional-neurology-devices-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically interventional neurology devices market is segmented into North America, Latin America, Middle East and Africa, Asia Pacific, and Europe. North America holds a significant share in interventional neurological devices market owing to increase in the prevalence of cerebrovascular disorders majorly in U.S., which is approximately 1,683 per 100,000 population. Moreover, rise in technological advancements, approval of novel products by FDA, and increase in healthcare expenditure are driving the interventional neurology devices market. Europe has a lucrative growth due to increase in prevalence of neurological disorders majorly in Russia, Latvia, Bulgaria, and Lithuania. In addition, technological advances in interventional neurological devices, well-developed healthcare infrastructure, and product approvals from EMEA are anticipated to bolster the interventional neurology devices market in the region. However, Asia Pacific is an emerging region for interventional neurology devices market due to rise in geriatric population majorly in India, China, and Japan, increase in the medical tourism, and growing demand for minimally invasive procedures in the region.

 

 

Some of the players in interventional neurology devices market are Medtronic plc) (Ireland), Stryker Corporation (U.S.), Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.), Abbott Laboratories (U.S.), Terumo Corporation (Japan), Bayer AG (Germany), Boston Scientific, Corporation (U.S.), and Penumbra, Inc. (U.S.) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-interventional-neurology-devices-market/]]>
Global Empty Capsules Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Fri, 16 Feb 2018 09:18:46 +0100 http://zend.comunicati.net/comunicati/istituzioni/comuni/veneto/comune_di_peschiera_del_garda/469952.html http://zend.comunicati.net/comunicati/istituzioni/comuni/veneto/comune_di_peschiera_del_garda/469952.html pbi pbi

Increase in the preference for vegetarian based empty capsules by various manufacturers, rise in the adoption of vegetarian empty capsules by the vegan groups, increase in the technological advancements, and attractive capsule design is the key factors expected to propel the empty capsules market growth. Furthermore, rise in consumer demand for capsules over tablets, and various advantages of capsules such as masking of unpleasant taste and odour of the drugs, increase the bioavailability and stability of the drugs expected to fuel the empty capsules market over the forecast period. However, the rise in prices of raw materials of empty capsules and socio-culture issues regarding the administration of gelatin capsules anticipated restraining the empty capsules market over the forecast timeframe.

 Global Empty Capsules Market

 Empty capsules are made up of gelatin, derived from the animal protein (such as pork skin, fish bones, and animal skin and bones) and plant polysaccharides (HPMC, pullulan, starch etc.). Empty capsules contain two parts namely a lower diameter or body filled with the various drugs and sealed with higher-diameter or cap. Various prescribed and OTC drugs, herbal drugs, and nutritional substances can be dispensed by filling in the empty capsules. Apart from this, empty capsules are also used to fill semi-solid and liquid dosage forms, especially for the drugs which have poor bioavailability, critical stability, poor water solubility, and low melting points etc. The advantages of the empty capsules are that they are low sensitive to oxygen permeability and have constant capsule dimensions.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-empty-capsules-market/#ulp-4H8Z4LpNMLEuOnnx  

 

 

Empty capsule market is segmented based on product type, application, route of administration, and end user

 

Based on the product type, empty capsules market is segmented into the following:

·         Gelatin or animal source capsules

·         Bovine source

·         Pork source

·         Bone meal

·         Others

·         Non-gelatin or plant source capsules

·         HPMC

·         Starch

·         Pullulan

 

Based on the application, empty capsules market is segmented into the following:

·         Antibiotics

·         Vitamins

·         Anti-inflammatory

·         Others

 

Based on the route of administration, empty capsules market is segmented into the following:

·         Oral

·         Inhalation

 

Based on the end user, empty capsules market is segmented into the following:

·         Pharmaceutical companies

·         Nutraceutical companies

·         Others

 

  To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-empty-capsules-market/#ulp-c654SbFYO64MsOhu

 

Global empty capsules market is in the developed stage with the availability of both gelatin and non-gelatin based capsules. Several local and international players are manufacturing the empty capsules with technological advancements such as enteric coated and extended release capsules, which release the drug for a long time. The usage of capsules is increased owing to its advantages such as taste and odour masking ability of the drugs and protection the drug from unfavourable atmospheric conditions. Acquisitions and mergers, collaborations, technological advancements, and diversification of business segment around the globe are some strategies followed by the companies to increase their revenue in the empty capsules market. For instance, in December 2016, Lonza Group AG has acquired the Capsugel from the KKR & Co LP for broadening its product range.

 

 

   Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-empty-capsules-market/#ulp-14mlyhjMGhVjZqa3

 

Geographically, empty capsule market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa. Increase in the R&D activities for various therapeutic drugs, rise in the prevalence of various diseases due to change in life style, increase in the healthcare expenditure, and rise in per capita income are anticipated to fuel the empty capsules market in the North America region. Moreover, Europe holds a dominant share, which is attributed to technological advancements in the empty capsules, increase in the healthcare expenditure, and increase in the demand for capsule consumption over the tablets are expected to bolster the empty capsules market in the Europe region. Asia Pacific is anticipated grow at significant rate owing to increase in the number of pharmaceutical and nutraceutical companies, ease of regulatory approvals in the nutraceutical industries, rise in healthcare expenditure, and increase in the prevalence of various infectious diseases might fuel the growth of the empty capsules market.

 

 

Some of the players in empty capsules market are ACG Worldwide (India), CapsCanada Corporation (Canada), Suheung Co., Ltd. (Korea), Qualicaps, Inc. (U.S.), Snail Pharma Industry Co. (China), Roxlor LLC (U.S.), Medi-Caps Ltd. (India), Lonza Group AG (Switzerland) and Bright Pharma Caps (U.S.) to name a few.

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-empty-capsules-market/

]]>